Trial Profile
A phase III trial of recombinant exendin-4 (Uni-E4) for the treatment of type-2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 May 2017
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Uni-Bio Science Group
- 16 May 2017 New trial record